Functional assessment of older people?
ADLs:
COOP: Drugs that cause confusion/affect memory?
Anti-psychotics
Benzodiazepines
Anti-muscarinics
Opioid analgesics
Some anti-convulsants
COOP: Drugs with a narrow therapeutic window?
Digoxin
Lithium
Phenytoin
Theophyllines
Warfarin
COOP: Drugs with a long half-life
Long acting benzos (nitrazepam & Diazepam_
Fluoxetine
Glibenclamide
COOP: drugs that cause hypothermia?
Anti-psychotics
TCA
COOP: drugs that cause Parkinsonism or movement disorders?
Metoclopramide
Antipsychotics
Prochlorperazine
COOP: Drugs that cause bleeding?
NSAIDs
Warfarin
COOP: drugs that predispose to falls?
Anti-psychotics
Sedatives
Anti-hypertensives (especially a-blockers, nitrates and ACE Inhibitors)
Diuretics
Antidepressants
Delirium?
Acute confusional state:
Disturbances of consciousness
Global disturbance of cognition (including illusions and visual hallucinations), disorientation in time place or person
Psychomotor disturbance
Disturbance of sleep-wake cycle
Emotional disturbance
Clinical evidence of an acute general medical condition, intoxication or substance withdrawal
Delirium causes?
Infection (UTI, Resp, Biliary) Acute hypoxaemia Electrolyte imbalance Meds MI Alcohol/benzo withdrawal Urinary retention Faecal impaction Neuro (Stroke, subdural haematoma, seizures), post-op
Delirium DDx?
Dementia
Depression
Mania
Schizophrenia
Dysphasia
Seizures
Conversion disorder
Delirium Ix?
AMTS
Look at drug chart
Confusion assessment method - Pt must display:
1st line:
Bedside: O2, urinalysis, ECG
Bloods: FBC, CRP, U+Es, Ca2+ , TFTs, LFTs, Glucose
Imaging: CXR
Consider:
Delirium Mx?
Treat underlying cause
Environment:
- Avoid overstimulation or sensory deprivation: treat in quiet side room with a clock
- Provide environmental and personal orientation
- Minimise discontinuity of care
- Encourage mobility, adequate fluids/nutrition and sleep pattern
Involve relatives and carers
Stop drugs that cause delirium
Pharmacological measures as last resort: Haloperidol 0.5mg or olanzapine
Falls
“Unintentionally coming to rest on the ground or some lower level and other than as a consequence of sustaining a violent blow, loss of consciousness or sudden onset of paralysis as in stroke or epileptic seizure”
Falls Risk factors
Social/demographic : eg. older, living alone, previous falls
Age-related changes - decreased ability to discriminate edges, reduced peripheral sensation, muscle weakness
Poor gait/balance - postural instability
Medical problems:
Meds
Environmental factors:
Falls Ix
History + examination
Get up an go test (get up from chair, no arms, walk 3m turn around, return to chair and sit down again):
20 pt needs assistance
Assess for acute illness: ECG, urine dipstick, U+Es, glucose , CRP, FBC
If abnormal gait & balance or recurrent falls: Medication review AMTS Vision assessment Lying & standing blood pressure Cardiovascular examination Neurological examination ECG
action:
Osteoporosis - Most common areas for fractures?
Spine
Wrist
Hip
Fracture/osteoporosis investigation?
Plan X-ray
DEXA:
Severe (established osteoporosis) : T score below -2.5 + one or more associated fragility fractures
Bloods: FBC, ESR, U+Es, CA2+, ALP, ALP, Phosphate, TFTs, LFTs, serum electrophoresis, urinary BJP, PTH, Vitamin D
Osteoporosis Mx?
Lifestyle changes: stop smoking, reduce alcohol intake, good calcium and vitamin D intake, regular weight bearing exercise
Calcium 1200mg and vitamin D 800IU
Meds:
Osteoporosis medication
Bisphosphonates:
Reduce bone turnover rate
Alendronate, risedronate and cyclic etidronate, are specifically licensed for the prevention and treatment of post-menopausal and glucocorticoid induced osteoporosis
only alendronate is licensed for use in men
1st line for secondary prevention of osteoporotic fragility in post-menopausal women
CI if patient has oesophagitis or impaired renal function
Raloxifene
2nd line for secondary prevention of osteoporotic fragility in post-menopausal women
Selective oestrogen receptor modulator
SE: increased risk of VTE and HTN
Teriparatide
2nd line for secondary prevention of osteoporotic fragility in post-menopausal women aged >65
Recombinant fragment of PTH
Strontium ranelate
Stimulates new bone formation and reduces bone resorption
SE: increased risk of VTE
Syncope causes?
Postural hypotension (most common)
Neurally mediated syncope (eg. vasovagal, situational syncope (micturation syncope))
Carotid sinus hypersensitivity
Structural cardiopulmonary disease (AS)
Cardiac arrhythmias:
- Sick sinus, AV blocks, Paroxysmal SVT/ VT, Long QT
Syncope Ix?
Review of medications
Cardiovascular examination
Neurological examination
Lying and standing BP
ECG
Tilt test / carotid sinus massage in patients with recurrent syncope and no structural heart disease
Cardiac investigations in patients with structural heart disease
Stroke causes?
Small vessel occlusion/cerebral microangiopathy or thrombosis in situ
Cardiac emboli
Atherothromboembolism
CNS bleeds (hypertension, trauma, aneurysm rupture, anticoagulation, thrombolysis)
Other causes: sudden BP drop >40mmHg, carotid artery dissection, vasculitis, subarachnoid haemorrhage, venous sinus thrombosis, anti-phospholipid syndrome, thrombophilia, Fabry’s disease (x-linked lysosomal storage disease)
Stroke: haemorrhagic vs ischaemic?
Pointers to bleeding: meningism, severe headache, coma within hours (unreliable pointers)
Pointers to ischaemia:
Carotid bruit, AF, past TIA, IHD
Cerebral infarcts: depending on site there may be contralateral sensory loss or hemiplegia – initially flaccid becoming spastic (UMN lesion); dysphasia; homonymous hemianopia; visuo-spatial